Advertisement
Research Article

Measuring Adiposity in Patients: The Utility of Body Mass Index (BMI), Percent Body Fat, and Leptin

  • Nirav R. Shah equal contributor,

    equal contributor Contributed equally to this work with: Nirav R. Shah, Eric R. Braverman

    Affiliation: Department of Medicine, New York University School of Medicine, New York, New York, United States of America

    Current address: New York State Department of Health, Albany, New York, United States of America

    X
  • Eric R. Braverman equal contributor mail

    equal contributor Contributed equally to this work with: Nirav R. Shah, Eric R. Braverman

    info@pathfounationny.org

    Affiliations: PATH Foundation NY, New York, New York, United States of America, Department of Neurosurgery, Weill-Cornell Medical College, New York, New York, United States of America

    X
  • Published: April 02, 2012
  • DOI: 10.1371/journal.pone.0033308

About the Authors

Nirav R. Shah
Department of Medicine, New York University School of Medicine, New York, New York, United States of America
Eric R. Braverman
PATH Foundation NY, New York, New York, United States of America
Eric R. Braverman
Department of Neurosurgery, Weill-Cornell Medical College, New York, New York, United States of America

Corresponding Author

Email: info@pathfounationny.org

Competing Interests

The authors have read the journal's policy and have the following conflicts: This work was supported by a research grant from the PATH Foundation. All research and financial support for this article preceded NRS's joining the New York State Department of Health. Similarly, except for minor editorial changes, the article was completed before that time. The views expressed in this article are solely those of the authors as individuals and do not represent the views or policies of the State of New York or the New York State Department of Health. During the period when the work was completed, NRS was also supported by grant 1 R01 HS01 8589-01. All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author and declare that (1) NRS has received grants from the PATH Foundation for the submitted work; ERB has received no personal compensation for the submitted work; (2) NRS has relationships with AstraZeneca, Pfizer, Merck, Ortho-McNeil, Roche, Shering-Plough, GlaxoSmithKline, Novartis, Partners Healthcare, Bellevue Hospital Association, NIH, AHRQ, CDC, Robert Wood Johnson Foundation, Cerner LifeSciences, Vemco MedEd, FAIR Health, Venebio Group, LLC, American Academy of Neurology, Pinnacle Health Geisinger Health System, MetaResearch, LLC, Johnson & Johnson, Takeda, Xcenda, Engage Healthcare, Medical Learning Institute, American Health & Drug Benefits, Center of Excellence Media LLC, Nassau University Medical Center, National Institute for Quality Improvement and Education and St. John's Episcopal Hospital. ERB has relationships with PATH Medical, Total Health Nutrients, Inc. and LLC, Life Extension Foundation, Weill-Cornell Medical College, the Stanley and Fiona Druckenmiller Fund, the American Academy of Anti-aging Medicine Fellowship in Anti-Aging, Regenerative, and Functional Medicine: Master's Degree in Metabolic & Nutritional Medicine in conjunction with the University of South Florida Medical School; the American Academy of Anti-aging Medicine Tarsus Medical Conference; and Douglas Labs, Life Extension Magazine; and has authored a book on weight loss; (3) Their spouses, partners, or children have no financial relationships that may be relevant to the submitted work; and (4) NRS and ERB have no non-financial interests that may be relevant to the submitted work. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: NRS ERB. Performed the experiments: NRS ERB. Analyzed the data: NRS ERB. Contributed reagents/materials/analysis tools: NRS ERB. Wrote the paper: NRS ERB.